Revoltz Model One is a micro-mobility vehicle for last mile and food delivery.
Medigus: Polyrizon to Test its Product Candidate for Protection Against High Transmissible Corona Virus Delta Variant B.1.617.2
In recent pre- clinical studies, Polyrizon products showed strong potential in preventing human coronavirus 229E and Influenza Virus H1N1 from interacting with epithelial host cells and by inhibiting cells' death.
Medigus: Polyrizon Submits a Patent Application for Prevention of Pathogens such as Coronavirus and Allergens from Affecting Nasal Tissue
In recent pre-clinical studies, Polyrizon products showed strong potential by preventing coronavirus and Influenza Virus H1N1 from interacting with epithelial host cells and by inhibiting cells' death.
Medigus: Gix Media to Acquire 70% of Leading Innovative Media-Tech Company Cortex Group for Approximately $11 Million
Gix Internet finished the first six months of 2021 with revenues of ~$ 16.4 million, Cortex Group Revenues for the first six months of 2021 amounted to ~$ 12.3 million
Medigus: Polyrizon’s Innovative Technology Found Effective Against Influenza Virus H1N1 in Cell Culture Assays
Polyrizon’s formulations previously demonstrated high efficacy by preventing coronavirus from interacting with epithelial host cells
More Articles ...
- Medigus: Jeffs’ Brands Ltd. Signed a Non-Binding LOI to Acquire a Leading Consumer Products Brand Company
- Medigus: Charging Robotics Successfully Completes a Proof of Concept for its Electric Vehicle Wireless Charging Robot
- Medigus Board of Directors Decides to Promote a $2 Million Buyback Program
- Medigus: Polyrizon’s innovative proprietary technology found effective against coronavirus in a pre-clinical study